register

ESG

Thank you for staying home this Easter from Australia’s blood cancer community

Health Industry Hub | April 14, 2020 |

Leading national blood cancer organisation the Leukaemia Foundation thanks Australians for following the recommended guidelines over the Easter Weekend as it struggles to continue supporting some of the nation’s most vulnerable people in the changing COVID-19 environment.

CEO Bill Petch said people living with blood cancer are faced with the constant challenge of a compromised immune system, and coming into contact with COVID-19 could be tragic.

“Social isolation is not a new concept to Australians living with blood cancer – it is something many of them are forced to do every day to ensure their health and safety. However, COVID-19 has added a new layer of concern for these Australians who are highly vulnerable to infection,” he said.

Mr Petch thanked every Australian who is stayed home and practised social distancing and, in doing so, played their part to keep safe the many children, adults and older Australians living with a blood cancer and helping to ease their anxieties during this unnerving time.

The Leukaemia Foundation is preparing for a shortfall in fundraising this year, with a number of community fundraising events being compromised or cancelled due to COVID-19, and the organisation is now working hard to continue offering vital support in a COVID-19 environment and beyond.

“Blood cancer doesn’t stop – even during a pandemic – and our concern is not only for the safety of our community today, but how we will continue to address the needs of more Australians being diagnosed with blood cancer in the future,” Mr Petch said.

“With 110,000 Australians already living with blood cancer and another 41 Australians diagnosed with the disease every day, the numbers are not in our favour when it comes to stretching our services to support all those in need.

“This week alone, we have had a spike in enquiries from Australians living with blood cancer wanting support and information on accessing their treatment, managing their infection risk and overall emotional support in this distressing time.

“We recognise that every Australian has been affected by the impacts of COVID-19 and we appreciate how difficult the last few weeks and months have been.

“The reality is our organisation is relying now more than ever on the generosity of Australians to help give people living with blood cancer someone to turn to, a place to call home during treatment and access to the best possible care, and we deeply appreciate any support through this time to continue this important work.”

To help support Australians living with blood cancer and ensure they continue to be able to access the support and information they need during the COVID-19 pandemic, the Leukaemia Foundation has launched an Emergency Appeal.


News & Trends - MedTech & Diagnostics

Labor's one-off funding a band aid for public hospitals while private sector left in limbo

Labor’s one-off funding a band aid for public hospitals while private sector left in limbo

Health Industry Hub | February 6, 2025 |

The Federal Government has committed a one-off funding boost of $1.7 billion to public hospitals under a one-year extension to […]

More


News & Trends - Pharmaceuticals

AI-powered test to reshape use of hormone therapy in prostate cancer

AI-powered test to reshape use of hormone therapy in prostate cancer

Health Industry Hub | February 6, 2025 |

Australian researchers are pioneering the use of artificial intelligence (AI) to enhance decision-making in prostate cancer treatment, specifically focusing on […]

More


News & Trends - MedTech & Diagnostics

Vantive debuts as standalone business amid complex landscape of chronic kidney disease

Vantive debuts as standalone business amid complex landscape of chronic kidney disease

Health Industry Hub | February 6, 2025 |

Vantive, formerly Baxter’s Kidney Care business, has officially launched as a standalone company. The move follows Baxter’s completion of the […]

More


News & Trends - MedTech & Diagnostics

Optalert unveils test for sleep apnoea as Philips expands partnership in pharmacy program

Optalert unveils test for sleep apnoea as Philips expands partnership in pharmacy program

Health Industry Hub | February 6, 2025 |

An Australian medical technology company has introduced a test designed to identify obstructive sleep apnoea (OSA), broadening access to sleep […]

More


This content is copyright protected. Please subscribe to gain access.